ロード中...
Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9
Lipoprotein(a) [Lp(a)] has been identified as a risk factor for cardiovascular disease. Lp(a) levels are also high under certain clinical conditions, including familial hypercholesterolemia and high blood low-density lipoprotein (LDL) cholesterol levels. Few effective generic therapies for modulatin...
保存先:
| 出版年: | J Thorac Dis |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5303088/ https://ncbi.nlm.nih.gov/pubmed/28203441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.01.40 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|